We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Coin-Sized Wearable Biosensing Platform Continuously Monitors Biosignals in Blood

By HospiMedica International staff writers
Posted on 15 Aug 2022

Organic electrochemical transistors are widely considered to be the next-generation sensing technology because of their water stability and high sensitivity at low operating voltage (milli-volts) but, until now, lacked a miniaturized wireless system to operate within. More...

Now, researchers have developed a coin-sized system that can read weak electrochemical signals, which can be used for personalized health monitoring and measurement of such conditions as diabetes, cardiovascular diseases and mental health.

The PERfECT System – an acronym for Personalized Electronic Reader for Electrochemical Transistors – developed by researchers at The University of Hong Kong (Hong Kong) is the world’s smallest system of its kind, measuring 1.5 cm x 1.5 cm x 0.2 cm and weighing only 0.4 grams. It is easily wearable, for instance integrated with a smartwatch or as a patch, to allow for continuous monitoring of biosignals such as glucose levels and antibody concentrations in blood and even sweat.

The PERfECT wearable system can precisely characterize the overall performance of the electrochemical transistor, with a data sampling rate as high as 200 kilosamples per second – a performance on par with bulky commercial equipment. But the price is only one-tenth of the commercial one. It can also serve as a miniaturized electrochemical station for wearable devices and measure the outputs of other kinds of low-voltage transistors, such as electrolyte-gated field effect transistors and high-k dielectric-gated thin-film transistors. The system could be applied immediately in multiple wearable systems that are based on low-voltage transistors.

“Our wearable system is tiny, soft and imperceptible to wearers, and it can do continuous monitoring of our body condition. These features mean it has the potential to revolutionize healthcare technology,” said Dr. Shiming Zhang of the Department of Electrical and Electronic Engineering, who is leading the HKU WISE (wearable, intelligent and soft electronics) Research Group to develop the system.

Related Links:
The University of Hong Kong


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Powered Surgical Stapler
ECHELON 3000 Stapler
New
Tracheostomy Tube
Portex BLUselect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.